CLXConsumer & retailthecloroxcompany.com
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025* | Sep 2025 | Dec 2025 | Mar 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $1.76B | $1.69B | $1.67B | $1.99B | $1.43B | $1.67B | $1.67B | $1.91B | ▲ +33.3% |
| Gross profit | $807.00M | $738.00M | $744.00M | $924.00M | $596.00M | $722.00M | $722.00M | $770.00M | ▲ +29.2% |
| Operating incomenever filed | — | — | — | — | — | — | — | — | — |
| Net income | $99.00M | $193.00M | $186.00M | $332.00M | $80.00M | $157.00M | $187.00M | $170.00M | ▲ +112.5% |
| R&D | $31.00M | $31.00M | $27.00M | $32.00M | $28.00M | $29.00M | $27.00M | $29.00M | ▲ +3.6% |
| EPS (diluted) | 0.80 $ | 1.54 $ | 1.50 $ | — | 0.65 $ | 1.29 $ | 1.54 $ | 1.39 $ | ▲ +113.8% |
| Margins (% of revenue) | |||||||||
| Gross | 45.8 % | 43.8 % | 44.6 % | 46.5 % | 41.7 % | 43.2 % | 43.2 % | 40.4 % | ▼ -1.3 pt |
| Operating | — | — | — | — | — | — | — | — | — |
| Net | 5.6 % | 11.4 % | 11.2 % | 16.7 % | 5.6 % | 9.4 % | 11.2 % | 8.9 % | ▲ +3.3 pt |
| Balance sheet | |||||||||
| Assets | $5.50B | $5.58B | $5.51B | $5.56B | $5.53B | $5.61B | $6.44B | $7.83B | ▲ +41.7% |
| Liabilities | $5.27B | $5.46B | $5.32B | $5.08B | $5.39B | $5.58B | $6.34B | $7.71B | ▲ +43.1% |
| Equity | $224.00M | $121.00M | $190.00M | $482.00M | $138.00M | $35.00M | $92.00M | $121.00M | ▼ -12.3% |
| Cash | $278.00M | $290.00M | $226.00M | $167.00M | $166.00M | $227.00M | $1.19B | $184.00M | ▲ +10.8% |
| Capital | |||||||||
| Shares outstanding | 123.78M | 123.19M | 123.25M | 122.31M | 121.98M | 120.91M | 120.92M | 121.15M | ▼ -0.7% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.